A PHASE 1, BLINDED, RANDOMIZED, DOSE ESCALATION TRIAL OF PFSPZ CHEMOPROPHYLAXIS VACCINATION (PFSPZ-CVAC) ON AN ACCELERATED SCHEDULE IN HEALTHY MALARIA-NAIVE ADULTS IN THE UNITED STATES

被引：0
|
作者：
Murphy, Sean C. [1 ]
Seilie, Annette M. [1 ]
Chang, Ming [1 ]
Kublin, James G. [2 ]
Sim, B. Kim Lee [3 ]
Richie, Thomas L. [3 ]
Hoffman, Stephen L. [3 ]
Jackson, Lisa A. [4 ]
机构：
[1] Univ Washington, Med Ctr, Seattle, WA 98195 USA
[2] Fred Hutch Canc Res Ctr, Seattle Malaria Clin Trials Ctr, Seattle, WA USA
[3] Sanaria Inc, Rockville, MD USA
[4] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2017年 / 97卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1106
引用
收藏
页码：344 / 344
页数：1
相关论文
共 22 条
  • [1] PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial
    Coulibaly, Drissa
    Kone, Abdoulaye K.
    Traore, Karim
    Niangaly, Amadou
    Kouriba, Bourema
    Arama, Charles
    Zeguime, Amatigue
    Dolo, Amagana
    Lyke, Kirsten E.
    Plowe, Christopher, V
    Abebe, Yonas
    Potter, Gail E.
    Kennedy, Jessie K.
    Galbiati, Shirley M.
    Nomicos, Effie
    Deye, Gregory A.
    Richie, Thomas L.
    James, Eric R.
    Kc, Natasha
    Sim, B. Kim Lee
    Hoffman, Stephen L.
    Doumbo, Ogobara K.
    Thera, Mahamadou A.
    Laurens, Matthew B.
    [J]. ECLINICALMEDICINE, 2022, 52
  • [2] CHEMOPROPHYLAXIS VACCINATION (PFSPZ-CVAC) WITH HIGH DOSE OF SANARIA® PFSPZ CHALLENGE NF54 UNDER PYRIMETHAMINE OR CHLOROQUINE LEADS TO PROTECTIVE EFFICACY AGAINST HETEROLOGOUS CONTROLLED HUMAN MALARIA INFECTION IN MALARIA NAIVE ADULTS
    Mwakingwe-Omari, Agnes
    Lane, Jacquelyn
    Cook, David M.
    Healy, Sara A.
    Pfeiffer, Susan
    Kalhori, Sahand
    Wyatt, Charles
    Marte-Salcedo, Omely
    Imeru, Alemush
    Nason, Martha
    Zaidi, Irfan
    Duan, Junhui
    Neal, Jillian
    Raiten, Jake
    Hume, Jen C. C.
    Jeon, Esther J.
    Fahle, Gary
    Murshedkar, Tooba
    Ruben, Adam J.
    Chakravarty, Sumana
    Manoj, Anita
    Gunasekera, Anusha
    Sim, B. Kim Lee
    Billingsley, Peter F.
    James, Eric R.
    Richie, Thomas L.
    Hoffman, Stephen L.
    Duffy, Patrick E.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 322 - 322
  • [3] PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial
    Coulibaly, Drissa
    Kone, Abdoulaye K.
    Traore, Karim
    Niangaly, Amadou
    Kouriba, Bourema
    Arama, Charles
    Zeguime, Amatigue
    Dolo, Amagana
    Lyke, Kirsten E.
    Plowe, Christopher, V
    Abebe, Yonas
    Potter, Gail E.
    Kennedy, Jessie K.
    Galbiati, Shirley M.
    Nomicos, Ef fie
    Deye, Gregory A.
    Richie, Thomas L.
    James, Eric R.
    Natasha, K. C.
    Sim, Kim Lee
    Hoffman, Stephen L.
    Doumbo, Ogobara K.
    Thera, Mahamadou A.
    Laurens, Matthew B.
    [J]. ECLINICALMEDICINE, 2022, 52
  • [4] T CELL IMMUNOGENICITY AND CORRELATES OF PROTECTION FROM A DOSE-ESCALATION SAFETY AND EFFICACY STUDY OF PFSPZ WITH CHLOROQUINE IN MALARIA-NAIVE ADULTS
    Ishizuka, Andrew S.
    Mordmueller, Benjamin
    Flynn, Barbara
    Ruben, Adam J.
    Li, Tao
    Sim, B. Kim Lee
    Hoffman, Stephen L.
    Kremsner, Peter
    Seder, Robert A.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 516 - 516
  • [5] CHEMOPROPHYLAXIS VACCINATION (CVAC) WITH SANARIA ® PFSPZ CHALLENGE AND PYRIMETHAMINE: PHASE 1 TRIAL TO DETERMINE SAFETY AND PROTECTIVE EFFICACY AFTER EXPOSURE TO ONLY PLASMODIUM FALCIPARUM LIVER STAGES
    Mwakingwe, Agnes
    Healy, Sara A.
    Lane, Jacquelyn
    Kolluri, Aarti
    Gabriel, Erin
    Zaidi, Irfan
    Duan, Junhui
    Hume, Jen C. C.
    Anderson, Charles
    Ding, Kelly
    Murshedkar, Tooba
    Ruben, Adam J.
    Chakravarty, Sumana
    Manoj, Anita
    Gunasekera, Anusha
    Sim, B. Kim Lee
    Billingsley, Peter F.
    James, Eric R.
    Richie, Thomas L.
    Hoffman, Stephen L.
    Duffy, Patrick E.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 127 - 127
  • [6] EXPERIENCE IN MANAGING SANARIA® PFSPZ VACCINE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED PHASE 1 CLINICAL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF PFSPZ VACCINE IN MALARIA-EXPERIENCED ADULTS IN BURKINA FASO
    Bougouma, Edith
    Soulama, Issiaka
    James, Eric
    Abebe, Yonas
    Ouedraogo, Alphonse
    Tiono, Alfred
    Koutiebou, Roland
    Gnima, Albert
    Kabore, Jean
    Billingsley, Peter
    Msnoj, Anita
    Richie, Thomas
    Lyke, Kirsten
    Plowe, Christopher
    Jones, Walter
    Laurens, Mathew
    Hoffman, Stephen
    Sirima, Sodiomon
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 360 - 360
  • [7] Immunogenicity and safety of an accelerated hepatitis E vaccination schedule in healthy adults: a randomized, controlled, open-label, phase IV trial
    Chen, Z.
    Lin, S.
    Duan, J.
    Luo, Y.
    Wang, S.
    Gan, Z.
    Yi, H.
    Wu, T.
    Huang, S.
    Zhang, Q.
    Lv, H.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (09) : 1133 - 1139
  • [8] Safety, tolerability, and Plasmodium falciparum transmissionreducing activity of monoclonal antibody TB31F: a singlecentre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults
    van der Boor, Saskia C.
    Smit, Merel J.
    van Beek, Stijn W.
    Ramjith, Jordache
    Teelen, Karina
    van de Vegte-Bolmer, Marga
    Van Gemert, Geert-Jan
    Pickkers, Peter
    Wu, Yimin
    Locke, Emily
    Lee, Shwu-Maan
    Aponte, John
    King, C. Richter
    Birkett, Ashley J.
    Miura, Kazutoyo
    Ayorinde, Morolayo A.
    Sauerwein, Robert W.
    ter Heine, Rob
    Ockenhouse, Christian F.
    Bousema, Teun
    Jore, Matthijs M.
    McCall, Matthew B. B.
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (11): : 1596 - 1605
  • [9] Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial
    Sissoko, Mahamadou S.
    Healy, Sara A.
    Katile, Abdoulaye
    Omaswa, Freda
    Zaidi, Irfan
    Gabriel, Erin E.
    Kamate, Bourama
    Samake, Yacouba
    Guindo, Merepen A.
    Dolo, Amagana
    Niangaly, Amadou
    Niare, Karamoko
    Zeguime, Amatigue
    Sissoko, Kourane
    Diallo, Hama
    Thera, Lsmaila
    Ding, Kelly
    Fay, Michael P.
    O'Connell, Elise M.
    Nutman, Thomas B.
    Wong-Madden, Sharon
    Murshedkar, Tooba
    Ruben, Adam J.
    Li, Minglin
    Abebe, Yonas
    Manoj, Anita
    Gunasekera, Anusha
    Chakravarty, Sumana
    Sim, B. Kim Lee
    Billingsley, Peter F.
    James, Eric R.
    Walther, Michael
    Richie, Thomas L.
    Hoffman, Stephen L.
    Doumbo, Ogobara
    Duffy, Patrick E.
    [J]. LANCET INFECTIOUS DISEASES, 2017, 17 (05): : 498 - 509
  • [10] A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naive adults
    Cummings, J. F.
    Polhemus, M. E.
    Kester, K. E.
    Ockenhouse, C. F.
    Gasser, R. A.
    Coyne, P.
    Wortmann, G.
    Nielsen, R. K.
    Schaecher, K.
    Holland, C. A.
    Krzych, U.
    Tornieporth, N.
    Soisson, L. A.
    Angov, E.
    Heppner, D. G.
    [J]. VACCINE, 2024, 42 (12) : 3066 - 3074
123